Browsing by Author "Ballensiefen, Wolfgang"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- How personalised medicine will transform healthcare by 2030: the ICPerMed visionPublication . Vicente, Astrid M.; Ballensiefen, Wolfgang; Jönsson, Jan-IngvarThis commentary presents the vision of the International Consortium for Personalised Medicine (ICPerMed) on how personalised medicine (PM) will lead to the next generation of healthcare by 2030. This vision focuses on five perspectives: individual and public engagement, involvement of health professionals, implementation within healthcare systems, health-related data, and the development of sustainable economic models that allow improved therapy, diagnostic and preventive approaches as new healthcare concepts for the benefit of the public. We further identify four pillars representing transversal issues that are crucial for the successful implementation of PM in all perspectives. The implementation of PM will result in more efficient and equitable healthcare, access to modern healthcare methods, and improved control by individuals of their own health data, as well as economic development in the health sector.
- The ICPerMed vision for 2030: How can personalised approaches pave the way to Next-Generation Medicine?Publication . Vicente, Astrid M.; Ballensiefen, Wolfgang; Donertas, Derya; Eklund, Malin; Ivask, Angela; Jönsson, Jan-Ingvar; Kuhlmann, Katja; Lawrence, Adrien; O’Driscoll, Mairead; Richer, Etienne; Trivella, Giovanna; on behalf of the Executive Committee of ICPerMedThis document presents the vision of the International Consortium for Personalised Medicine (ICPerMed) on personalised medicine (PM) research and implementation by 2030. ICPerMed connects more than 40 European and international institutions that aim to: The notion that individuals can experience unique clinical manifestations for the same disease, as well as variable responses to treatment, has long been recognized by the medical community. There are many long-standing paradigmatic examples of the use of such knowledge in medicine, for example the testing of blood type before blood transfusions or the neonatal screening programs. However, the prolific technological advancements in biomarker detection over the last few decades, including not only genomics but also other “omics” and body imaging methods, have spurred the development of novel approaches to health and disease management that are specifically optimised for each individual. The term PM, and its subtle variations, such as precision medicine or stratified medicine, today generally describe an approach to medicine that integrates an individual’s characteristics for early disease diagnosis, prognosis, optimal choice of treatment, accurate disease risk estimation, and targeted prevention.